There is no record of Trump making such a comment and the DOD confirmed it is "not taking down content" related to Bradley.
CAMBRIDGE, Mass., May 11, 2023 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical stage genome editing company, today announced that a scientific abstract detailing safety and ...
Editas Medicine's reduced R&D costs and strong cash position provide operational comfort but necessitate future capital, especially amid looming competition from exa-cel. EDIT-301 shows early promise ...
CAMBRIDGE, Mass., Dec. 06, 2022 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical stage genome editing company, today announced positive, initial clinical data from the first two ...